Pregabalin Capsule
Product Images NDC 67877-463

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 67877-463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pregabalin 100 90

Each hard gelain capsule contains Swazomyny Pregabalin Capsules. This is prescription information and the capsules should be stored at room temperature. The label should have a UV varnish. The manufacturer is Al Lacostonss Lt NOW. P and distributed by Hans Ibonis LC Ascend. No information is available about the purpose or use of this medication.*

FDA Label Image

Pregabalin 150 90

FDA Label Image

Pregabalin 200 500

FDA Label Image

Pregabalin 225 90

FDA Label Image

Pregabalin 25 90

This seems to be a medication label with information regarding prescription, storage, dosage, manufacturer, and distribution instructions. The medication is Pregabalin capsules accompanied by an information guide that should be given to each patient along with the medication. The label provides the usual dosage and storage conditions, including the temperature range and precautions to be taken to prevent tampering. The medication is manufactured by Al Lacorstonss Ltd, and distributed by Hsans Abomis Lc and ASCEND Pasgany NS GENR. The size of each capsule is 5 pobSHE and the label should have a UV varnish.*

FDA Label Image

Pregabalin 300 90

Each hard gelatin capsule contains 90 mg of Pregabalin. The accompanying prescribing information should be consulted for dosage and use instructions. These capsules should be dispensed in a controlled room temperature environment. The manufacturer is U E Laboratories located in India and the distributor is Asomnd Laboratories LC in Parsppany, New Jersey. The product is labeled as Pregabalin Capsules and includes an NDC number. This medication is available by prescription only and should be accompanied by a medication guide given to each patient. The remaining text is unreadable.*

FDA Label Image

Pregabalin 50 500

FDA Label Image

Pregabalin 75 10

This text seems to be a list of medication of Pregabalin, with capsules of the same drug made by different companies. There isn't much useful information contained in this text besides the identification of the drug and the presentation.*

FDA Label Image

Pregabalin 75 100

FDA Label Image

Pregabalin-equation (Pregabalin Equation)

This appears to be a formula used to calculate creatinine clearance (CLCr) based on age, weight, and serum creatinine levels in female patients. Without additional information on the units used and any associated medical context, it is difficult to provide a more detailed description.*

FDA Label Image

Pregabalin-figure-6 (Pregabalin Figure 6)

This appears to be a results table from two different studies ("Study E1" and "Study E3") comparing the effects of different doses of an unidentified medication versus a placebo. The table includes some percentages, though it is not clear what they are measuring. The last line mentions that some data were statistically significant compared to the placebo, but without more context, it is impossible to say what this means.*

FDA Label Image

Pregabalin-figure-7 (Pregabalin Figure 7)

FDA Label Image

Study Dpn 1 (Pregabalin Image 1)

FDA Label Image

Study Sci 1 (Pregabalin Image 10)

FDA Label Image

Pain Intensity-study Sci 2 (Pregabalin Image 11)

FDA Label Image

Study Dpn 2 (Pregabalin Image 2)

FDA Label Image

Study Phn 1 (Pregabalin Image 3)

FDA Label Image

Study Phn 2 (Pregabalin Image 4)

FDA Label Image

Study Phn 3 (Pregabalin Image 5)

FDA Label Image

Fibromyalgia Study F1 (Pregabalin Image 8)

This appears to be a chart showing the percentage of patients who experienced improvement in pain from baseline while taking different daily doses of Pregabalin and Fiacsto. The chart shows that the 100mg daily dose of Pregabalin resulted in the most significant improvement in pain, with 100% of patients showing improvement. However, without additional context, it is difficult to determine the full meaning or purpose of this chart.*

FDA Label Image

Fibromyalgia Study F2 (Pregabalin Image 9)

FDA Label Image

Pregabalin Structure (Pregabalin Srtuc 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.